BridgeMD
Positron emission tomography (PET) of patients with brain injury and athletes with concussion symptoms - Descriptive study of the tau tracer 18F-RO6958948
EU CTIS ID: 2024-517048-67-00
What this study is testing
The primary objective is to study if tau is increased in the brain compared to the normal population and where in the brain the uptake occures.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- The subject/patient has given his written consent to participate in the study.
- Age 18-60 years.
- The patient is judged by the investigator to be clinically stable enough to pass the examination with PET, and understand the study information.
- Study population A-C (patients with TBI, ICH or SAH): Cared for in the intensive care unit NIVA with one of the diagnoses traumatic brain injury (TBI), intracerebral haemorrhage (ICH) or subarachnoid haemorrhage (SAH). During the care period, relatives have been informed and did not object to participation.
- Study population D (athletes): Athletes age 18-40 years, The athlete has suffered from at least one previous concussion in sports and has persistent symptoms, The athlete must have had symptoms (post-emotional syndrome) for at least 6 months after the last concussion.
You likely can't join if
- Claustrophobia.
- Pregnancy, breast-feeding or planned pregnancy.
- Mental inability, reluctance or language difficulties that make it difficult to understand the meaning of participating in the study.
- Treatment or illness which, according to the examiner, may affect the treatment or the study result.
- Participates in or has recently participated in a clinical trial in the last 6 months.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.